Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Parkinsonism & Related Disorders|July 5, 2021
Determining an efficient deep brain stimulation target in essential tremor - Cohort study and review of the literatureDorothee Kübler, Daniel Kroneberg, Bassam Al-Fatly, et al.
Frontiers in Neurology|July 29, 2022
Objective Observer vs. Patient Motor State Assessments Using the PD Home Diary in Advanced Parkinson's DiseaseJonathan Timpka, Matthias Löhle, Alexander Bremer, et al.
The Journal of Nervous and Mental Disease|January 1, 2013
Reduced body mass index in Parkinson's disease: contribution of comorbid depressionMaximilian Pilhatsch, Nils B Kroemer, Christine Schneider, et al.
Parkinsonism & Related Disorders|March 5, 2013
Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal deliveryThomas Müller, Teus van Laar, David R Cornblath, et al.
Cells|February 14, 2019
Dynamics of Parkinson's Disease Multimodal Complex Treatment in Germany from 2010⁻2016: Patient Characteristics, Access to Treatment, and Formation of Regional CentersDaniel Richter, Dirk Bartig, Siegfried Muhlack, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 13, 2015
Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)Alexander Storch, Christine B Schneider, Lisa Klingelhöfer, et al.
Journal of Parkinson'S Disease|October 3, 2022
Fear of Progression is Determined by Anxiety and Self-Efficacy but not Disease-Specific Parameters in Patients with Parkinson's Disease: Preliminary Data from a Multicenter Cross-Sectional StudyAnn-Kristin Folkerts, Lena Haarmann, Jörn Nielsen, et al.
Frontiers in Neurology|July 17, 2018
Do We Need to Rethink the Epidemiology and Healthcare Utilization of Parkinson's Disease in Germany?Sebastian Heinzel, Daniela Berg, Sebastian Binder, et al.
Frontiers in Neurology|September 9, 2022
The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A <i>post-hoc</i> analysis of BIPARK-I and IIJosé-Francisco Rocha, Georg Ebersbach, Andrew Lees, et al.
Frontiers in Neurology|November 22, 2021
The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A <i>Post-hoc</i> Analysis of BIPARK-I and -IIJosé-Francisco Rocha, Georg Ebersbach, Andrew Lees, et al.
Pageof 9